GLAM
IDIX

Gardner Lewis Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Gardner Lewis Asset Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-109,275
Closed -$2.63M – 124
2014
Q2 		$2.63M Buy
+109,275
New +$1.14M 0.73% 46

Gardner Lewis Asset Management's IDIX Position: Q3 2014 in Review

Gardner Lewis Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 109,275 shares — an estimated $2.63M sold.

Gardner Lewis Asset Management first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $2.63M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Gardner Lewis Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 109,275 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.63M.
  • Gardner Lewis Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Gardner Lewis Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $2.63M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.